Clinical trial
Influence of the Administration of Autologous Bone Marrow Mononuclear Cells for the Duration of Functioning Aorto-coronary Bypass Grafts in the Surgical Treatment of Coronary Heart Disease
NCT02059512 is registered in ClinicalTrials.gov with St. Petersburg State Pavlov Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Influence of the Administration of Autologous Bone Marrow Mononuclear Cells for the Duration of Functioning Aorto-coronary Bypass Grafts in the Surgical Treatment of Coronary Heart Disease
- Lead sponsor
- St. Petersburg State Pavlov Medical University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 28, 2013
- Completion date
- January 31, 2018
- Enrollment
- 117 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bone marrow cells, coronary artery bypass grafting (cabg), heart failure, diastolic, ischemic heart disease